Stay Updated with the Latest Alpine Immune Sciences, Inc. ALPN News in Real Time
Find ALPN news now at Meyka AI. Stay informed with the latest Alpine Immune Sciences, Inc. stocks updates, including price news, market analysis, and expert insights.
Mowi (OSE: MOWI) Shares Rise 3.4% as Q2 Salmon Harvest Tops Guidance and EBIT Climbs 23%
Mowi shares rose 3.4% Wednesday after the salmon farmer’s Q2 trading update beat expectations. Mowi reported operational EBIT of EUR 231 million, up 23% from EUR 189 million. The company harvested 150,000 tonnes during the quarter, a record for any second quarter. That volume topped Mowi’s own guidance of 140,000 tonnes by a wide margin. …
Biocon (NSE: BIOCON) Shares Jump 8.04% to 52-Week High After ₹400 Block Deal
On July 14, 2026, Biocon (NSE: BIOCON) shares climbed 8.04% to a fresh 52-week high after reports of a ₹400-per-share block deal involving a large institutional shareholder. The news led to heavy trading and renewed interest in one of India’s leading biopharmaceutical companies. Large block deals often raise questions about changes in ownership, but they…
Alpine Texworld IPO GMP Today: Grey Market Premium Holds at ₹X as Issue Opens on Day 1
Alpine Texworld IPO opened for subscription on July 14, 2026, and investors are watching its Grey Market Premium (GMP) along with the first day’s bidding. The IPO is priced between ₹100 and ₹105 per share and aims to raise ₹126.25 crore through a fresh issue. The GMP has remained steady since the issue opened, though…
SK Hynix Stock News: ₩2,203,000 Share Price as Korea Eyes Major AI Factory Funding Reform
SK Hynix shares traded around ₩2,203,000 on July 14, 2026, after investors responded to South Korea’s proposal to relax funding rules for large AI semiconductor factory projects. If approved, the changes would make it easier for chipmakers to raise capital to expand advanced manufacturing capacity at a time when global demand for AI memory chips…
Q32 Bio (NASDAQ: QTTB) Jumps 60% on Strong 36-Week Clinical Data for Hair Loss Treatment
On 13 July 2026, Q32 Bio (NASDAQ: QTTB) became one of the biggest gainers in the biotech sector after its shares climbed about 60% on the back of positive 36-week Phase 2a clinical results for its experimental alopecia areata treatment, bempikibart. The latest data showed meaningful hair regrowth in patients with severe hair loss while…
Trump Shifted $1.4 Billion in Crypto Earnings Into Stocks and Bonds, Financial Filings Show
On 13 July 2026, newly released financial filings revealed that Donald Trump shifted a substantial portion of his $1.4 billion in crypto earnings into stocks and bonds. The disclosure caught attention because Trump has remained one of the strongest public supporters of digital assets in recent years. Rather than keeping most of his wealth in…
Fluazinam Fungicide Faces EU Withdrawal Push After Brain Development Study July 12
Swedish researchers expose regulatory fraud in EU pesticide approval: fluazinam fungicide linked to brain development harm in rats, yet remains approved across Europe and Switzerland.
TCS Jumps 4% on Q1 Revenue Beat and $2.6B AI Revenue Surge
TCS stock surges 4% after Q1 results beat estimates with ₹72,275 crore revenue and $2.6B annualized AI revenue. Meyka rates TCS A-, forecasting ₹3,291 by year-end.
Meta Jumps 6% to $669 on AI Cloud Business and Strong Cash Flow
Meta stock rallies 6% to $669.21 on July 11, 2026, driven by AI cloud monetization strategy and $64.5B annual free cash flow. Meyka rates META a B with neutral outlook.